Eye Disorders

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.1 — Medical Care · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.2 — Rendering Of Medical Services · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.3 — Positive Patient Response · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.4 — Re-Evaluate Treatment · page 8 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.5 — Education · pages 8–9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.6 — Acuity · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.7 — Initial Evaluation · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.8 — Diagnostic Time Frames · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.9 — Treatment Time Frames · page 9 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.10 — Delayed Recovery · pages 9–10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.11 — Active Interventions · page 10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.12 — Active Therapeutic Exercise Program · page 10 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.13 — Diagnostic Imaging And Testing Procedures · pages 10–11 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.14 — Surgical Interventions · page 11 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.15 — Pre-Authorization · page 11 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.16 — Psychological/Psychiatric Evaluations · pages 11–12 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.17 — Personality/Psychological/Psychosocial Intervention · pages 12–13 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.18 — Functional Capacity Evaluation (FCE) · page 13 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.19 — Return To Work · page 13 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.20 — Job Site Evaluation · page 14 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.21 — Guideline Recommendations And Medical Evidence · page 14 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.22 — Experimental/Investigational Treatment · page 14 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.23 — Injured Workers As Patients · page 14 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ A.24 — Scope Of Practice · pages 15–17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ B.1 — Definitions · page 17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ B.2 — Risk and Causation · page 17 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ B.3 — General Approach and Principles · pages 17–18 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1 — Presenting Symptoms · pages 18–19 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.a — History · pages 19–21 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.b — Red Flags · pages 21–22 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.c — Examination · pages 22–24 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.d.i — Visual Acuity: Quantitative Bilateral Tests. Acuity is · page 24 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.d.ii — Slit-Lamp Biomicroscopy. Slit-lamp examination is the standard method of examining the eye. The slit lamp · page 24 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.1.d.iii — How to Interpret the Findings of Red Eye. The · pages 24–26 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.2 — Diagnostic Approach · page 26 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.2.a — Special Studies and Diagnostic and Treatment Considerations · pages 26–27 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.2.b — Selection of Special Studies · pages 27–28 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.3 — Diagnostic Criteria · pages 28–30 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.4 — Management Approach · pages 30–31 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.a — Vision Screening · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.a.i — Vision Screening for Post-injury Examinations · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.a.ii — Vision Screening for Postoperative Examinations · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.b — Color Vision Screening · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.b.i — Color Vision Screening for Select Post-injury · page 32 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.b.ii — Color Vision Screening for Select Postoperative · pages 32–33 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.c — Peripheral Vision Testing · page 33 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.c.i — Peripheral Vision Screening for Select Post-injury · page 33 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.c.ii — Peripheral Vision Screening for Select Postoperative · pages 33–34 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.d — Depth Perception Testing · pages 34–35 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.d.i — Depth Perception Screening for Select Post-Injury · page 35 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ C.5.d.ii — Depth Perception Screening – Post-Operative · pages 35–36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.1.a — Medical History · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.1.b — Onset · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.1.c — Current treatments used · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.1.d — Prior injuries and prior treatments · page 36 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.1.e — Red Flags · pages 36–37 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.2 — Diagnosis · pages 37–38 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.3 — Diagnostic Recommendations · pages 38–39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.3.a — Visual Acuity Testing When Evaluating Eye Conditions · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.3.b — Use of Slit Lamp and Fluorescein Stain for Evaluation and Diagnosis of Foreign Body and Corneal Abrasion · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.4 — X-Rays · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.4.a — X-Ray for Evaluation of Orbital Fracture · page 39 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.4.b — X-Ray for Evaluation of Ocular Foreign Bodies · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.4.c — X-Ray for Evaluation for Simple Abrasions, Rust Rings, and Non-Penetrating/Non-Metallic Foreign Bodies · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.5 — Computed Tomography (CT) · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.5.a — CT for Evaluation of Ocular Foreign Bodies · page 40 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.5.b — CT for Evaluation of Possible Orbital Fracture · pages 40–41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.6 — Magnetic Resonance Imagery (MRI) · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.6.a — MRI for Diagnosis of Foreign Body and Corneal Abrasion · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.7.a — Foreign Body Removal · page 41 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.7.a.i — Copious Irrigation for Removal of Superficial Foreign · pages 41–42 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.7.a.ii — Foreign Body Removal of Superficial Foreign · page 42 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.7.a.iii — Removal of Rust Ring · pages 42–43 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.7.a.iv — Eye Patching · page 43 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8 — Medications · page 43 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.a — Prophylactic Ophthalmic Antibiotics for Simple Corneal · page 44 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.b — Prophylactic Ophthalmic Antibiotics for Organic Matter Injuries · page 44 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.c — NSAID Drops after Removal of Rust Ring or Foreign Body · page 44 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.d — Topical Antifungal Medications · page 44 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.e — Therapeutic Contact Lens for Corneal Abrasions, Rust Rings, · pages 44–45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.f — Epidermal Growth Factor (EGF) for Corneal Abrasions, Rust · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.g — Mydriatic Medications for Simple Corneal Abrasions, Rust · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.h — Mydriatic Medications for Severe or Complicated Corneal · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.i — Artificial Tears or Lubrication for Extensive Corneal Abrasions, · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.j — Artificial Tears for Corneal Abrasions, Rust Rings, and Foreign · page 45 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ D.8.k — Topical Opioids for Analgesia of Corneal Abrasions, Rust · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.1 — Corneal Lacerations · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.1.a — Retinoic acid · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.1.b — Rigid gas-permeable contact lenses · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.1.c — Hyper Stabilization of the intraocular foreign body without · page 46 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2 — Blunt Trauma and Traumatic Hyphema · pages 46–47 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.a — X-rays · page 47 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.b — CT scans · page 47 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.i — Topical Aminocaproic Acid for Traumatic Hyphema · pages 47–48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.ii — Tranexamic Acid for Traumatic Hyphema · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.iii — Topical Cycloplegics · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.iv — Topical Corticosteroids · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.v — Systemic Corticosteroids · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.vi — Rigid Shield · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.vii — Activity Restriction · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.2.c.viii — Inpatient Management · page 48 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3 — Viral, Bacterial, and Fungal Infections and Corneal · pages 48–49 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.a — Risk Factors · pages 49–50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.b — Medical History · page 50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.c — Onset · page 50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.d — Treatments typically used at presentation: · page 50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.e — Red Flags · page 50 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.f.i — Initial Assessment · page 51 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.f.ii — Diagnostic Criteria · pages 51–53 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.g.i — Adenovirus Screening · pages 53–54 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.g.ii — Adenovirus Screening, Routine · page 54 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ E.3.g.iii — Gram Stain, Potassium Iodide (KOH) preparation, · page 54 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.1 — Initial Care · page 54 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a — Medications · pages 54–55 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.i — Antibiotics for Bacterial Conjunctivitis and Bacterial · pages 55–56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.ii — Adjuvant Glucocorticosteroids for Bacterial · page 56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.iii — Antibiotics for Viral Conjunctivitis · page 56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.iv — Non-steroidal Anti-inflammatory Drugs for Symptoms · page 56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.v — Glucocorticosteroids for Symptoms of Viral · page 56 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ F.2.a.vi — Antifungal Medications for Fungal Conjunctivitis and Fungal Infections Complicating Corneal Ulcers · pages 56–58 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ G.1.a — Daily Lid Hygiene for Blepharoconjunctivitis · page 58 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ G.1.b — Antibiotics for Blepharoconjunctivitis · page 58 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ G.1.c — Steriods for Blepharoconjunctivitis · pages 58–59 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.1 — Red Flags · pages 59–60 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.2 — Diagnosis · pages 60–62 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.2.a.i — High Molecular Weight Specific Antigens · page 62 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.2.a.ii — IgG Specific Immunological Testing for High · page 62 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.2.a.iii — Low Molecular Weight Specific Antigens · page 62 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.3 — Treatment · pages 62–63 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.3.i — Management of Allergic Eye Symptoms without Asthma · page 63 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.3.ii — Education for Allergic Conditions · page 63 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.4 — Medications · page 64 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.4.a — Antihistamine and/or Mast Cell Stabilization Medications for Allergic Diseases · page 64 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.4.b — NSAID Eye Drops for Allergic Diseases · pages 64–65 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ H.4.c — Glucocorticosteroid Eye Drops · pages 65–66 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1 — Treatment · page 66 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.a — Copious Irrigation for Chemical Eye Exposures · pages 66–67 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.b — Irrigating Systems (e.g., Morgan Lens) for Chemical Eye · pages 67–68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.c — Artificial Tears or Lubrication for Chemical Ocular Burns · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.d — NSAID Ophthalmic Drops for Chemical Ocular Burns · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.e — Glucocorticosteroid Drops for Chemical Ocular Burns · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.1.f — Eye Patching for Chemical Ocular Burns · page 68 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.2 — Surgical Interventions · pages 68–69 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.2.a — Medical Contact Lens(es) · page 69 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.2.b — Amniotic Membrane Transplantation (AMT) · page 69 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.2.c — Corneal Transplantation · page 69 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ J.2.d — Hyperbaric Oxygenation · pages 69–70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.a — NSAID Ophthalmic Drops · page 70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.b — Eye Patching · page 70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.c — Copious Irrigation · page 70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.d — Irrigating Systems (e.g., Morgan Lens) for Thermal Eye · page 70 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.e — Artificial Tears or Lubrication for Thermal Ocular Burns · pages 70–71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.f — NSAID Ophthalmic Drops · page 71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.g — Eye Patching for Thermal Ocular Burns · page 71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.h — Amniotic Membrane Transplantation with Medical Therapy for Thermal Ocular Burns · page 71 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ K.1.i — Standalone Amniotic Membrane Transplantation for Acute · pages 71–72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ L.1.a — NSAID Ophthalmic Drops · page 72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ L.1.b — Glucocorticosteroid Drops for Inflamed Pterygia or Pingueculae · page 72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ L.1.c — Pterygium Surgical Excision for Pterygia · page 72 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).

NY WCB Eye Disorders Medical Treatment Guidelines, First Edition (September 28, 2021), effective for treatment on or after 2022-05-02 — governing edition per 12 NYCRR § 324.2(a)(15).

§ L.1.d — Bevacizumab · pages 72–73 of the guideline.

The guideline text is published by the Workers' Compensation Board and is not reproduced here. Read the section in the WCB PDF (link above). Care that departs from the guideline requires a variance under 12 NYCRR § 324.3; procedures over $1,000 that follow it are pre-authorized under § 324.2(d).